CG Oncology Inc. Common stock (CGON) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for CG Oncology Inc. Common stock, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
CG Oncology Inc. Common stock (CGON) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $5.6B. It trades at $63.96, up 1.62% today. Its overall quality score is 31 out of 100, ranked against the whole US market. 10 analysts' average target of $92.30 implies +44.3% from today's price. Kronos AI's 30-day forecast is +10.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $92.30 |
| Low – high | $79.00 – $108.00 |
| Analysts | 10 |
| Upside to average | +44.3% |
Kronos AI 30-day forecast
| Expected close | $69.37 (+10.2%) |
| Likely range | +2.2% … +13.9% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 10 |
| Solvency | 56 |
| Growth | 28 |
| Overall | 31 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator